CTOs on the Move

Parexel

www.parexel.com

 
PAREXEL International Corporation is the world`s leading innovator of biopharmaceutical services. We simplify our clients` journey of transforming scientific discoveries into new medical treatments for patients with high-quality Phase I-IV clinical research, regulatory, consulting and market access services. PAREXEL develops breakthrough innovations and solutions by leveraging its comprehensive therapeutic, technical and functional expertise, in more than 100 countries around the world.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.parexel.com
  • 195 West Street
    Waltham, MA USA 02451
  • Phone: 781.487.9900

Executives

Name Title Contact Details
Anthony Sofo
Director, IT Security Profile
Gary Swartz
Senior Director, Client Technology Partner Profile
Anthony Carrillo
Associate Director, Information Security, Americas Profile
Gavin Nichols
Executive Vice President of Informatics and Information Technology Profile

Jobs

Senior Director HR Operations

Parexel Waltham, Massachusetts
Job Description :
1. Overall Accountability
Lead the North and South America HR Operations team. Develop the performance capabilities of client groups and of the HR Operations Team in order to increase PAREXEL competitive advantage. Drive quality and process improvement in all HR Operations services. Drive and deliver operational execution ...

Similar Companies

Blue Sky Biotech Inc

Blue Sky Biotech Inc is a Worcester, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Genelux

Genelux is a late clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company`s most advanced product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a proprietary, modified strain of the vaccinia virus. Olvi-Vec currently is being evaluated in OnPrime/GOG-3076, a multi-center, randomized, open-label Phase 3 registrational trial evaluating the efficacy and safety of Olvi-Vec in combination with platinum-doublet + bevacizumab compared to platinum-doublet + bevacizumab in patients with platinum-resistant/refractory ovarian cancer. The core of Genelux` discovery and development efforts revolves around the company`s proprietary CHOICE™ platform from which the Company has developed an extensive library of isolated and engineered oncolytic vaccinia virus immunotherapeutic product candidates, including Olvi-Vec.

Talis Biomedical

Talis is developing a new class of diagnostic platform to enable rapid, high-complexity testing across a wide range of healthcare settings.

NextCure

NextCure is a fully integrated biotechnology company discovering and developing first-in-class immunotherapy-based biologics for cancer and other diseases. The company is focused on understanding biological pathways and leveraging our FIND-IOTM technology to discover, validate and build a proprietary pipeline. We believe identifying and targeting immune pathways will promote identification of effective targets for mediating sustained immunity leading to improved outcomes for cancer patients.

Omnicare Distribution Center

Omnicare Distribution Center is a Toledo, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.